GSK and Pfizer merge consumer branches
GlaxoSmithKline (GSK) and Pfizer have merged the parts of their companies selling retail and over-the-counter products into one business.
Following the completion of the merger of the consumer arms of GSK and Pfizer on August 1, the two companies have established the single business under the name of GSK Consumer Healthcare.
The new venture combines each manufacturer’s brands into one portfolio that includes Sensodyne, Voltarol, Panadol, Corsodyl, Anadin, Centrum and Nexium.
GSK Consumer Healthcare is “the world’s number one over-the-counter business”, GSK said.
Jon Workman, who leads GSK Consumer Healthcare, said: “We are embarking on a long-term self-care movement with the aim of sustaining a shift in the behaviours of the nation – getting people to think ‘pharmacist first’ and avoid unnecessary visits to the GP and A&E in the longer term.”